The cystatin C polymorphism is not associated with early onset Alzheimer's disease

Neurology

Volumn 57, Issue 2, 2001, Pages 366-367

  Roks, G ^a   Cruts, M ^b   Slooter, A J C ^a,c   Dermaut, B ^b   Hofman, A ^a   Van Broeckhoven, C ^b   Van Duijn, Cornelia M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; ONSET AGE; PRIORITY JOURNAL;

EID: 0035943062     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.2.366-a     Document Type: Article

References (7)

1. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study
2. A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease
3. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease
4. Cerebral amyloid angiopathy: An overview
5. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases
6. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease
7. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease